Adial Pharmaceuticals (ADIL) Q3 2024 Earnings

13AugConfirmed
Q2 2023
Q3 2023
Q2 2024
Q3 2024
-2.19
-1.48
-0.77
-0.06

Details

Expected EPS
-0.54
Actual EPS
-0.59
Surprise EPS
-0.05
Surprise Percent
+9.26%

Description

Adial Pharmaceuticals (ADIL) has reported earnings of -0.59 per share for Q3 2024.

0 Comments

Share your thoughts